Expansion of Community Health Programs by Novar...

By João L. Carapinha

April 9, 2026

Novartis’ ambitious scale-up of community health programs aims to close critical gaps in cardiovascular and cancer care. Announced on April 9, 2026, the initiative will expand these community health programs from 11 to more than 30 countries by 20...
Differentiated Visceral Fat Reduction in Early Trials of WVE-007
Impact of Insulin Copay Caps on Medicare Beneficiary Health and Spending
Advancements in Immunotherapy for Hepatocellular Carcinoma: EMERALD-3 Trial R...
Facilitating Reimbursement for Intravesical Gemcitabine in Bladder Cancer Tre...
100% Tariffs Impacting Pharmaceutical Manufacturing and National Security
FDA Approves Once-Weekly Basal Insulin Awiqli® for Type 2 Diabetes Management
Inflation Reduction Act Impact on Clinical Trial Investment Trends
Vitamin B6 Depletion Risk in Carbidopa/Levodopa Therapy and Seizure Implications
Citation Analysis of Real-World Evidence in Medicare Drug Price Negotiations
Cost-Effectiveness of T1D Screening Effectiveness in Canadian Children
Wegovy HD Approval: A Game Changer in Obesity Treatment and Weight Loss Efficacy
Long-Term HPV Vaccine Effectiveness: Sustained Protection Against Cervical Di...